Radiopharmaceuticals Market 2019 with Top Companies Analysis: Cardinal Health, MallinckrodtPlc., GE Healthcare, Lantheus Medical Imaging, Bayer AG, Bracco Imaging SpA, Nordion, IBA Molecular Imaging, CovidienPlc, Positron Corporation, NTP Radioisotopes

Radiopharmaceuticals are the drugs that can be used for either diagnostic or therapeutic purpose. This are administered to the patient and are monitored through specific imaging devices. Radiopharmaceuticals are also used in bone pain. They have preferential uptake into bone. Phosphorous 32 was the compound which was used in treating pain from bony metastases. Other radiopharmaceuticals use for this purpose are strontium-89 and samarium-153, which are commercially available in U.S. Earlier the conventional chemotherapy methods were used but now this methods have been replace by radiopharmaceuticals for cancer treatment. In diagnosis and evaluation of the prostate cancer Gallium 68 has played a very important role.

According to the guide to the nuclear wallchart around 30 million peoples are hospitalize each year. Out of which one third are treated with nuclear medicine, that is more than 10 million nuclear medicine procedure are performed and more than 100 million of nuclear medicine tests are performed each year. Today there are almost 100 isotopes used in diagnosis and therapy.

Download PDF Sample Copy of Report Visit @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market

Market Segmentation:

1. By Type
o Diagnostic
o Therapeutic Radiopharmaceuticals

2. By Procedural Volume

o Diagnostic Procedures
 Single-Photon Emission Computed Tomography Radiopharmaceuticals
 Positron Emission Tomography Radiopharmaceuticals
I. Therapeutic Procedures
 Beta Emitters
 Alpha Emitters
 Brachy Therapy

3. By Application

Diagnostic Application
 Single-Photon Emission Computed Tomography
 Cardiology
 Lymphoma
 Thyroid
 Neurology
 Others

II. Positron Emission Tomography
 Oncology
 Cardiology
 Neurology
 Others

III. Therapeutic Application
 Thyroid
 Bone Metastasis
 Lymphoma
 Endocrine Tumors
 Others

4. By Sources
o Nuclear Reactors
o Cyclotrons

Request for Table of Content of Full Report @ https://databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market

5. By End User
o Hospitals
o Ambulatory Surgical Centers
o Diagnostic Centers
o Cancer Research Institutes
o Others

6. By Geography
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa

Top Challengers:

• Cardinal Health Inc.
• MallinckrodtPlc.
• GE Healthcare
• Lantheus Medical Imaging Inc.
• Bayer AG
• Bracco Imaging SpA
• Eczacibasi-Monrol Nuclear Products
• Nordion Inc.
• Advanced Accelerator Applications S.A.
• IBA Molecular Imaging
• Actinium Pharmaceuticals Inc.,
• Among others.

This reports includes the following deliverable

Macro Indicator Analysis
Market Overview
Market Dynamics
Drivers, Restraints, Opportunities and Challenges
Market sizing and growth analysis
Market forecasting to 2024
Market Competitive Landscape
Product Launches and Pipeline Analysis
Value Chain Analysis
Market Mergers, Acquisitions and Agreements
Company Profiles

Any Specific Requirements? Questions? Ask to Our Industry Expert @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiopharmaceuticals-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.